The Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) is a global public-private partnership dedicated to raising and disbursing financial resources to prevent and treat HIV/AIDS, tuberculosis (TB), and malaria. Since its creation in 2002, the Global Fund has become a major funding channel for programs to fight these three diseases. As of December 2013, it had signed grants worth a total of US$29 billion in more than 140 countries.
The Global Fund provided 22% of all international financing for HIV/AIDS in 2012. In 2013, it is estimated to have supplied around 75% of international funding for TB control. The World Malaria Report 2013 found that the Global Fund was the single largest source of funding for malaria control, accounting for an estimated 50% of total international disbursements in 2013.
As a public-private partnership representing governments, civil society, the private sector, and affected communities, the Global Fund represents a new model of international health financing. Its success relies on the financial pledges of donors, the technical support of multilateral agencies, and the development and implementation of programs by in-country partners. Its governance body is the Global Fund Board (referred to in this profile as "the Board").
Source: Global Fund website: Our Principles
The partnership is currently undergoing a far-reaching reform process with significant changes in its business model. A key element of this process is its strategy for 2012-2016, called Investing for Impact, adopted at the Board Meeting in November 2011 (see Strategic objectives and associated strategic actions, below, which shows the five strategic objectives for 2012-2016).
At the same meeting, the Board adopted a Consolidated Transformation Plan which sought to move the Global Fund from a past focus on emergency funding to a new funding approach based on strategic investment of resources for achieving sustainable impact. Among other recommendations, the plan called for:
As a key process in implementing the 2012-2016 Strategy and transformation plan, the Board approved a New Funding Model (NFM) in November 2012. The model establishes a funding allocation system aimed at focusing grants on countries with the highest disease burden and the least ability to pay. It seeks to increase funding predictability by providing countries with an indicative funding amount for a three-year allocation period and gives countries flexibility to decide when to apply for funding within this period. In February 2013, the transition period of the NFM was launched and full implementation will begin in March 2014.